Could a common antidepressant prevent a serious pancreas complication?
NCT ID NCT06860984
First seen Nov 18, 2025 · Last updated May 21, 2026 · Updated 27 times
Summary
This study tests whether the drug duloxetine can prevent pancreatitis (inflammation of the pancreas) after a procedure called ERCP, which is used to diagnose and treat bile duct problems. About 44 adults with bile duct disease will receive duloxetine before the procedure to see if it lowers their risk of developing this painful complication. The goal is to find a safe and effective way to prevent a common and serious side effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tanta Unuversity
RECRUITINGTanta, 31527, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.